Perfetto Candice O, Murugappan Gayathree, Lathi Ruth B
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Stanford University Medical Center, 900 Welch Rd, Suite 15, Palo Alto, CA USA 94304.
Fertil Res Pract. 2015 Apr 21;1:5. doi: 10.1186/2054-7099-1-5. eCollection 2015.
The current standard of care for management of patients with recurrent pregnancy loss is expectant management. However, the emotional impact of pregnancy losses and the urgency to conceive often leads couples to consider a variety of fertility treatments. The objective of this study is to report the time to next pregnancy and subsequent live birth and miscarriage rates in fertile patients with recurrent pregnancy loss (RPL) who choose to attempt spontaneous conception compared to those that opt to pursue fertility treatment.
Retrospective cohort study of one hundred and fifty-eight fertile RPL patients treated at a university-based fertility center. Patients were followed for a minimum of 6 months. Patients were encouraged to attempt spontaneous conception, but allowed to initiate fertility treatments (ovarian stimulation, insemination, IVF or PGS) according to their preferences. Main outcome measures were time to next pregnancy and pregnancy outcome.
For those patients who achieved a spontaneous conception, 88% conceived within 6 months, with a median time of 2 months and range of 1-10 months. Patients using IUI, IVF and PGS conceived in a median of 3, 4 and 5 months, respectively. The live birth rate and clinical miscarriage rate was not improved with any fertility treatment.
In the fertile RPL patient population, there does not appear to be a benefit to proceeding directly with fertility treatment. Patients should be encouraged to attempt spontaneous conception for at least 6 months.
复发性流产患者目前的标准治疗方案是期待治疗。然而,流产带来的情感影响以及迫切想要怀孕的心情常常促使夫妇考虑各种生育治疗方法。本研究的目的是报告与选择接受生育治疗的复发性流产(RPL)可育患者相比,选择尝试自然受孕的患者下次怀孕的时间、随后的活产率和流产率。
对在一家大学附属生育中心接受治疗的158例可育RPL患者进行回顾性队列研究。对患者进行至少6个月的随访。鼓励患者尝试自然受孕,但允许他们根据自己的意愿开始生育治疗(卵巢刺激、人工授精、体外受精或植入前基因筛查)。主要观察指标为下次怀孕时间和妊娠结局。
对于那些自然受孕的患者,88%在6个月内受孕,中位时间为2个月,范围为1至10个月。接受宫腔内人工授精(IUI)、体外受精和植入前基因筛查的患者受孕的中位时间分别为3、4和5个月。任何生育治疗均未提高活产率和临床流产率。
在可育的RPL患者群体中,直接进行生育治疗似乎没有益处。应鼓励患者尝试自然受孕至少6个月。